Reports for ABBVIE CORPORATION
Company Name
ABBVIE CORPORATION
Totals |
||
Shortage reports |
111 |
|
| Actual shortage: | 2 (2%) | |
| Anticipated shortage: | 1 (1%) | |
| Avoided shortage: | 5 (5%) | |
| Resolved: | 103 (93%) | |
Discontinuation Reports |
9 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 8 (89%) | |
| Reversed: | 1 (11%) | |
Late reports |
3 (3%) |
|
Overdue reports |
2 (67%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ZYMAR | 0.3% | SOLUTION | Resolved | 2017-08-03 | 2017-10-13 | 18241 |
| SURVANTA | 25MG | SUSPENSION | Resolved | 2018-07-27 | 2018-08-30 | 56829 |
| ACUVAIL | 0.45% | SOLUTION | Resolved | 2018-10-09 | 2018-10-19 | 63456 |
| CONSTELLA | 290MCG | CAPSULE | Resolved | 2018-11-20 | 2019-01-09 | 67153 |
| ALPHAGAN P | 0.15% | SOLUTION | Resolved | 2019-01-21 | 2019-01-23 | 73016 |
| BYSTOLIC | 5.0MG | TABLET | Resolved | 2018-12-05 | 2019-02-08 | 68675 |
| BELKYRA | 10MG | SOLUTION | Resolved | 2018-11-01 | 2019-02-16 | 65967 |
| ACULAR | 0.5% | SOLUTION | Resolved | 2018-11-06 | 2019-02-21 | 66328 |
| BYSTOLIC | 10.0MG | TABLET | Resolved | 2019-01-29 | 2019-02-22 | 73787 |
| CONSTELLA | 290MCG | CAPSULE | Resolved | 2019-02-19 | 2019-02-27 | 76263 |
| VIIBRYD | 10MG | TABLET | Resolved | 2019-01-15 | 2019-02-28 | 72344 |
| ACULAR | 0.5% | SOLUTION | Resolved | 2019-02-15 | 2019-03-15 | 75873 |
| OZURDEX | 0.7MG | IMPLANT | Resolved | 2019-02-21 | 2019-03-21 | 76570 |
| ACUVAIL | 0.45% | SOLUTION | Resolved | 2019-03-20 | 2019-04-26 | 78953 |
| OZURDEX | 0.7MG | IMPLANT | Resolved | 2019-04-08 | 2019-04-27 | 80819 |
| VIIBRYD | 20MG | TABLET | Resolved | 2019-01-15 | 2019-05-09 | 72342 |
| VIIBRYD | 10MG | TABLET | Resolved | 2019-02-28 | 2019-05-14 | 77159 |
| BELKYRA | 10MG | SOLUTION | Resolved | 2019-02-19 | 2019-05-22 | 76311 |
| BYSTOLIC | 10.0MG | TABLET | Resolved | 2019-05-25 | 2019-06-06 | 84746 |
| BYSTOLIC | 2.5MG | TABLET | Resolved | 2019-05-25 | 2019-06-07 | 84750 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MODERIBA | 600MG | TABLET | Discontinued | 2017-11-20 | 2018-05-07 | 29835 |
| TECHNIVIE | 12.5MG 75MG 50MG | TABLET | Discontinued | 2017-11-20 | 2018-05-07 | 29839 |
| HOLKIRA PAK | 50MG 12.5MG 250MG 75MG | KIT TABLET | Discontinued | 2017-11-30 | 2018-08-30 | 31302 |
| MODERIBA | 400MG | TABLET | Discontinued | 2017-11-30 | 2018-08-30 | 31316 |
| MODERIBA | 200MG | TABLET | Discontinued | 2017-11-21 | 2018-08-30 | 29907 |
| NORVIR | 80MG | SOLUTION | Discontinued | 2019-02-20 | 2019-04-01 | 76354 |
| HUMIRA | 40MG | SOLUTION | Discontinued | 2020-06-29 | 2020-11-19 | 119141 |
| LUPRON | 5MG | SOLUTION | Discontinued | 2022-01-31 | 2022-08-17 | 153896 |
| ALPHAGAN | 0.2% | LIQUID | Reversed | 2021-12-09 | 2023-12-14 | 150885 |
Showing 1 to 9 of 9